4-Bromo-2,3,5,6-tetrafluorobenzotrifluoride, 97.0%, 10g

tert-Butyl (3S)-4-{6-[(5-chloro-2-methoxypyridin-3-yl)amino]pyridin-3-yl}-3-methylpiperazine-1-carboxylate, 98%, 100mg

Acido acetico, min 99%, per sintesi, 5 l, confezione in plastica.

2-Aminobenzo[b]thiophene-3-carbonitrile, 95.0%, 250mg

N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine, 95.0%, 1g

(2E)-3-(2-methylphenyl)-1-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 2g

(S)-4-ISOPROPYL-2-(4-(TRIFLUOROMETHYL)PYRIDIN-2-YL)-4,5-DIHYDROOXAZOLE, 95%, 250mg

(S)-4-(4-((4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic acid compound with benzenesulfonic acid (1:1), 98%, 1g

6-Amino-1,3,3-trimethylindolin-2-one, 95.0%, 100mg

(S)-5-(Aminomethyl)-1-(5,7-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)-1H-imidazole-2(3H)-thione hydrochloride, 95.0%, 5mg

4-Methoxy-2-nitrobenzaldehyde�, 97.0%, 250mg

2-(2,3,4-Trichlorophenyl)quinoline-4-carboxylic acid, 97%, 250mg

3-Butyl-1H-pyrazole-5-carboxylic acid, 50mg